Navigation Links
JResultNet Interface Engine Software

ProductsJResultNet Interface Engine Software
Company Dawning Technologies, Inc.
Item JResultNet Interface Engine Software
Features 
  • A Complete Connection Manager: A single copy of JResultNet software can coordinate the connection of a large number of peripheral interfaces to an LIS and/or connections to other information systems.
  • Complete Message Mapping Control: JResultNet is primarily designed to work with the HL7 and ASTM industry standard protocols.
  • Audit Trails: An Audit Log feature is included in JResultNet.
  • Password Controlled Access: JResultNet provides three levels of password access control.
  • JResultNet Rules Plug-in Features: JResultNet software includes several levels of user definable rules that can modify performance of the interface system.
  • Optional Modules: Broadcast Manager Module, Bio-Rad Unity Pro Connection Module, Ancillary System Connection Modules, Network Instrument Connection Modules, Downtime ID Module, Access 2000 Database Module
Description JResultNet Interface Engine Software is a powerful Java-based interface engine application that is commonly used to control laboratory instrument connections and LIS front-end data management. JResultNet is used in two applications: embedded in the JavaLin interface and/or installed stand-alone on a network PC station. Within the JavaLin, JResultNet provides the means of communicating directly from the analyzer location using properly mapped HL7, ASTM or Common Data Format messaging. On the PC platform, JResultNet can exercise many additional features ranging from control of a large population of instrument and system connections to powerful rules based processing in an autovalidation environment. Dawning has implemented a common user interface across all products, simplifying training efforts.

When used in combination with Dawning interface products, a distributed architecture is established that reduces demand on the LIS or other centralized CPU's and also reduces network traffic considerably compared to straight in instrument connection models using terminal servers. JResultNet provides several means of remote access. Users can access JavaLin units or a PC based JResultNet from many remote locations, no extra charge. Remote access can be accomplished via a local Java utility or via a standard Web browser. At the heart of JResultNet are powerful and flexible mapping tools that can parse incoming HL7, ASTM or CDF messages into individual fields and build outgoing messages in similar fashion in any desired format. JResultNet can also handle system-to-system connections and can be used as an embedded application with another DMS, eliminating the need to develop external interface capabilities.

Info Dawning Technologies, Inc.
Customer Service: (800) 332-0499

Related medicine products :

1. Gulani Interface Spatula
2. Stealthstation Siemens Siremobil Iso-C3D C-Arm Imaging System Interface
3. Accumedic Electronic Medical Record Software Interface / Patient Demographics
4. Reference Lab Interface (RLI)©
5. DNA Engine Opticon Continuous Fluorescence Detection System
6. DNA Engine Opticon 2 Continuous Fluorescence Detection System
7. PTC-225 DNA Engine Tetrad™ Cycler
8. DNA Engine thermal cycler chassis
9. DNA Engine Thermal Cycler Chassis
10. DNA Engine Thermal Cycler Chassis, w/96-well block & motorized lid
11. AeroScout Engine: Software for Reliable Visibility
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...ay the a new vaccine effective against the 1918 de...u has been developed//. This is likely to lead to ...which may may the jump into humans and turn just a...anish flu,thought to have been triggered off by un...
...sue of the journal Radiology revealed that accurat...a three-dimensional computed tomography (CT) colon...want to be screened by this method when it is cove...e experience with virtual colonoscopy screening co...
...ociation has published a report on Tuesday about a...ly prescribed and OTC crugs have caused// many a p...lised. The sample data for the study consisted of...ing 2004 and 2005, and it was determined from this...
...to get overweight youngsters lose weight by concen...ff and are likely to make them// gorge even more, ...t they are no more motivated to change their eatin... happy with their appearance. Rather the researc...
Other Medicine News:Health News:Virtual Colonoscopy in Colorectal Cancer Prevention and Screening 2Health News:Virtual Colonoscopy in Colorectal Cancer Prevention and Screening 3Health News:Obese Kids Unmotivated byWeight Loss campaigns 2
(Date:10/7/2008)... Showed Larazotide Acetate Prevented Immunologic C...ts with Celiac Disease, Additional Data Indicates ... ORLANDO, Fla., Oct. 7 /- Alba Therap...ical studies this week at the American,College of ...ing. Data from,study CLIN 1001-004, the first Phas...
(Date:10/7/2008)...a clinical study of adults, VYVANSE taken once-dai...hin one week, PHILADELPHIA, Oct. 7 /PRNewswire-Fi...he global specialty biopharmaceutical company, tod...er issue of the Journal of,Clinical Psychiatry fou...tion Deficit Hyperactivity Disorder (ADHD) symptom...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Scientific ...tCall/ -- Ironwood,Pharmaceuticals, Inc. (formerly...SE: FRX ) today announced the presentation of res... safety and efficacy in 420 patients with,irritabl...is of the data,indicates that once- daily oral dos...
(Date:10/7/2008)...KELEY, Calif., Oct. 7 /- Aerovance In...data from a Phase I trial of its Aerovant,inhalati...no evidence of,local irritancy following asthma pa...10 mg dose will be the highest of three doses inve...dy, which is scheduled to begin early,next year. E...
Breaking Medicine Technology:Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Simons Foundation awards Emory scientists 243M for autism gene research 674 1Simons Foundation awards Emory scientists 243M for autism gene research 674 2DURECT to Present at 2007 BIO Investor Forum 2871 1AspenBio Pharma to Present the Edgewater Research Investor Conference 1060 1AspenBio Pharma to Present the Edgewater Research Investor Conference 1060 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 1The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 2The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 3The Food Allergy 26 Anaphylaxis Network 28FAAN 29 and Verus Pharmaceuticals Work Together to Raise Awareness of Food Allergies 1056 4
...Show Potential of microRNAs as,Novel Cancer Drug T...ersey, July 05, 2007,/PRNewswire-FirstCall/ -- Ros...nounced today research published in the journal,Mo...tute of Science,and Rosetta Genomics . The finding...roRNA (miR-34a) to be used as a drug candidate,in ...
...INATE, Italy - July 4, 2007 - Cosmo Pharmaceutical...ary results from its,phase II/III study with CB-01.... CB-01-11 is a broad spectrum, semi-synthetic,ant...form. Through,the use of Cosmo,s MMX(tm) technolog...olon, bacteria in the gastro intestinal tract,that...
Other Medicine Technology:Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 2Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 3Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 4Rosetta Genomics and Weizmann Institute Scientists Identify Role of,microRNA in Cancer Suppression 5Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III,Data with Rifamycin MMX in Infectious Diarrhea 2